Health

Anti-infective therapy for infections caused by drug-resistant gram-negative pathogens now in Phase I study – Outbreak News Today – Outbreak News Today

By NewsDesk @infectiousdiseasenews Biopharmaceutical company, Qpex Biopharma, announced this week the initiation of a Phase…

Published

4 years ago

June 20, 2021

Noosa Online News Publisher

By NewsDesk @infectiousdiseasenews
Biopharmaceutical company, Qpex Biopharma, announced this week the initiation of a Phase 1 study of QPX9003, a next generation intravenous (IV)-administered synthetic polymyxin for infections caused by drug-resistant…

Click here to view the original article.

Related Topics:Australia Outbreak News Today

Up Next

SARS, MERS, COVID-19 and Disease X? Another pandemic may still be ahead of us. But what could it be? – ABC News

Don't Miss

Father of 8 was set to get 2nd vaccine dose, but contracted COVID-19 and died – wphm.net

Noosa News20 hours ago

Reubhan Ralph identified as man behind terrifying childcare centre incident in Peregian Springs on the Sunshine Coast

General18 hours ago

Police say new leads being pursued after baby’s body found in Alexander Heights stormwater drain

General22 hours ago

Man dies at shopping centre car park at Charlestown following reports of assault

Noosa News22 hours ago

Women’s Softball World Cup 2027 Redcliffe Brisbane

Noosa Online News

Anti-infective therapy for infections caused by drug-resistant gram-negative pathogens now in Phase I study – Outbreak News Today – Outbreak News Today

Trending